ELDN
Eledon Pharmaceuticals, Inc.
Biotechnology · Healthcare · United States
2.77
close · 2026-10-30
value
34
cheaper than peers34
quality
50
stronger fundamentals50
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, latest year | -18.8% | 57 |
| cash flow yield, 3 years ago | -12.6% | 52 |
| earnings yield, 1 year ago | -23.8% | 52 |
| cash flow yield, 1 year ago | -21.0% | 47 |
| cash flow yield, 2 years ago | -17.6% | 46 |
| price to book | 3.11× | 44 |
| cash flow yield, latest year | -27.7% | 37 |
| earnings yield, 2 years ago | -135.0% | 27 |
| earnings yield, 3 years ago | -222.4% | 20 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 0.6% | 79 |
| operating margin | 0.0% | 50 |
| return on equity | -110.7% | 23 |
3 of 4 measures available
Facts
| market cap | $225M |
| free cash flow | -$45.1M |
| employees | 33 |
| first trade | 2014-09-17 |
| next earnings | not reported |
| fundamentals updated | 2026-08-17 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.52 | -0.66 | -3.74 | -6.16 |
| free cash flow | -$62.3M | -$47.3M | -$39.5M | -$28.4M |
| net income | -$45.6M | -$36.2M | -$116.5M | -$88.0M |
| revenue | $0 | $0 | $0 | $0 |
| unusual items | $33.4M | $30.9M | -$76.2M | -$48.6M |